Pronóstico del mercado de partículas similares a virus de Oriente Medio y África hasta 2028: impacto de COVID-19 y análisis regional por tipo de producto (hepatitis, cáncer/VPH y enfermedad de Gaucher), fuente (levadura, células de insectos, plantas y otros) y aplicación (Vacunas y Terapéuticas)

Introducción al mercado

Los Emiratos Árabes Unidos (EAU), Arabia Saudita y Sudáfrica son los principales países de Oriente Medio y Asia. Región de África. Arabia Saudita fue el mercado más grande de partículas similares a virus en esta región en 2021. El mercado de partículas similares a virus en Medio Oriente y China fue el mayor mercado de partículas similares a virus en esta región en 2021. Se prevé que África Arabia Saudita crezca a una tasa compuesta anual más alta durante el período previsto; este crecimiento se atribuye a la creciente prevalencia de diversas enfermedades y al aumento de las iniciativas gubernamentales en términos de financiación y políticas relacionadas con la atención sanitaria.

Las incertidumbres económicas y los conflictos en curso están empeorando la situación en la región. . Por ejemplo, países como Siria, Libia y Yemen están sufriendo conflictos violentos y no pueden implementar ninguna medida de salud pública. Irán se encontraba en una profunda recesión económica debido a las sanciones estadounidenses. Además, las condiciones financieras más estrictas también están disminuyendo las actividades económicas en la región. Muchos países se enfrentan a una escasez de vacunas COVID19 en la región. Varios países desarrollados en desarrollo de las regiones se están quedando atrás en el suministro de vacunas COVID19. Por lo tanto, existe la posibilidad de que los fabricantes mundiales de vacunas exploren la sección sin explotar de Oriente Medio y África. Por ejemplo, según los datos publicados en la Brookings Institution en agosto de 2021, la vacunación en los países de ingresos bajos y medianos de África del Medio Oriente se estimó en un 25% en Jordania y un 27% en Marruecos, ningún país de África del Medio Oriente ha sido capaces de proporcionar a más del 15% de su población una dosis de la vacuna. Por lo tanto, ofrece un mercado potencial para el mercado relacionado con VLP en la región e impacta positivamente el mercado de VLP en la región.

Descripción general y dinámica del mercado

El mercado de partículas similares a virus en Oriente Medio y Asia. Se espera que África crezca de 152,83 millones de dólares en 2021 a 249,12 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 7,2% de 2021 a 2028. Varios actores del mercado de la salud y organizaciones de investigación participan activamente en las innovaciones y desarrollos de productos. El uso de partículas similares a virus es un enfoque emergente utilizado en la industria biofarmacéutica. Como las partículas similares a virus carecen de contenido viral, son más fáciles de manejar que los componentes virales reales. Las VLP se pueden utilizar para ayudar en la administración de fármacos, la obtención de imágenes, la inmunoterapia y la teragnóstica. Por ejemplo, según un estudio publicado en el NCBI en junio de 2020, las VLP se pueden utilizar en forma de nanopartículas en aplicaciones como terapia fototérmica, imágenes PET y CT, portadores de agentes de contraste para resonancia magnética, imágenes ópticas, vacunas contra enfermedades inflamatorias y autoinmunes. inmunoterapia contra el cáncer y administración de fármacos de moléculas pequeñas (en la terapia contra el cáncer). Por lo tanto, se espera que estas aplicaciones potenciales de VLP brinden oportunidades de crecimiento a los actores del mercado durante el período de pronóstico.

Segmentos clave del mercado

En términos de tipo de producto, el segmento de hepatitis representó la mayor proporción de las ventas en Oriente Medio y Europa. Mercado africano de partículas similares a virus en 2021. En términos de fuente, el segmento de levadura representó la mayor proporción del mercado de Oriente Medio y Europa. Mercado africano de partículas similares a virus en 2021. En términos de aplicación, el segmento de vacunas tuvo una mayor participación de mercado en el mercado de partículas similares a virus en 2021.

Principales fuentes y empresas enumeradas

Algunas de las principales fuentes primarias y secundarias mencionadas para preparar este informe sobre el mercado de partículas similares a virus en Medio Oriente Este y África son sitios web de empresas, informes anuales, informes financieros, documentos de gobiernos nacionales y bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son Merck & Co., Inc.; GlaxoSmithKline plc.; Pfizer Inc.; Sanofi; Serum Institute of India Pvt. Limitado. Limitado.; BHARAT BIOTECNOLOGÍA; LG Química; y VBI Vaccines Inc., entre otros.

Informe de razones para comprar

Comprender Oriente Medio y Oriente Medio. Panorama del mercado de partículas similares a virus de África e identifique los segmentos de mercado que tienen más probabilidades de garantizar un fuerte retorno
Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio de Medio Oriente &erio; Mercado africano de partículas similares a virus
Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en Medio Oriente y Asia. Mercado de partículas similares a virus de África al identificar los segmentos de mercado con las ventas probables más prometedoras
Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos de Medio Oriente &erio; Mercado africano de partículas similares a virus
Obtenga un pronóstico de ingresos de mercado para varios segmentos desde 2021-2028 en Medio Oriente y Asia. Región de África.

Oriente Medio y África. Segmentación del mercado de partículas similares a virus en África

< span>Medio Oriente y Asia Mercado de partículas similares a virus en África: por tipo de producto

Hepatitis
Cáncer/VPH
Enfermedad de Gaucher

Oriente Medio y África Mercado africano de partículas similares a virus: por fuente

levadura
insecto Célula
Planta
Otros

< fuerte>Medio Oriente y Asia Mercado de partículas similares a virus en África: por aplicación

Vacunas
Terapéutica

Oriente Medio y Oriente Medio Mercado africano de partículas similares a virus: por país

Arabia Saudita
Sudáfrica
EAU
Resto de MEA ;

Oriente Medio y Asia. Mercado de partículas similares a virus en África: empresas mencionadas

Merck & Co., Inc. ; &n bsp ;
GlaxoSmithKline plc.
Pfizer Inc. ; &n bsp ; &n bsp ;
Sanofi ; ;
Serum Institute of India Pvt. Limitado. Ltd.
BHARAT BIOTECH ; &n bsp ;
LG Chem ;
VBI Vaccines Inc. ;

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Virus-like Particles Market – By Product Type

1.3.2 Middle East & Africa Virus-like Particles Market – By Source

1.3.3 Middle East & Africa Virus-like Particles Market – By Application

1.3.4 Middle East & Africa Virus-like Particles Market – By Country

2. Middle East & Africa Virus-like Particles Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Virus-like Particles Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Experts Opinion

5. Middle East & Africa Virus-like Particles Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Higher Prevalence of Infectious Viral Diseases

5.1.2 Fostering Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2 Market Restraints

5.2.1 Existence of Alternative Technologies for Viral Vaccine Production

5.3 Market Opportunities

5.3.1 Increasing Potential Applications in Therapeutics and Diagnostics

5.4 Future Trends

5.4.1 Regular Demand for Innovative and Effective Products

5.5 Impact Analysis

6. Middle East & Africa Virus-like Particles Market Analysis

6.1 Middle East & Africa Virus-like Particles Market Revenue Forecast and Analysis

7. Middle East & Africa Virus-like Particles Market Analysis – by Product Type

7.1 Overview

7.2 Middle East & Africa Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3 Hepatitis

7.3.1 Overview

7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4 Cancer/ Human Papillomavirus (HPV)

7.4.1 Overview

7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5 Gaucher Disease

7.5.1 Overview

7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8. Middle East & Africa Virus-like Particles Market Analysis – By Source

8.1 Overview

8.2 Middle East & Africa Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3 Yeast

8.3.1 Overview

8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4 Plant

8.4.1 Overview

8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5 Insect Cell

8.5.1 Overview

8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Virus-like Particles Market Analysis – By Application

9.1 Overview

9.2 Middle East & Africa Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3 Vaccines

9.3.1 Overview

9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4 Therapeutics

9.4.1 Overview

9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Virus-like Particles Market – Country Analysis

10.1 Overview

10.1.1 Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1 UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4 UAE: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.1.5 UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2 Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4 Saudi Arabia: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.2.5 Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3 South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 South Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4 South Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.3.5 South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4 Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4 Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.4.5 Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Middle East & Africa Virus-like Particles Market

11.1 Impact Assessment of COVID-19 Pandemic

12. Middle East & Africa Virus-like Particles Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Merck & Co., Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 GlaxoSmithKline plc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Pfizer Inc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Sanofi

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Serum Institute of India Pvt. Ltd.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 BHARAT BIOTECH

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 LG Chem

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 VBI Vaccines Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Middle East & Africa Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2. UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 3. UAE Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 4. UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5. Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 6. Saudi Arabia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 7. Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8. South Africa Virus-like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

Table 9. South Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10. South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11. Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 12. Rest of Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 13. Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14. Organic Developments Done by Companies

Table 15. Inorganic Developments Done by Companies

Table 16. Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES

Figure 1. Middle East & Africa Virus-like particles Market Segmentation

Figure 2. Middle East & Africa Virus-like particles Market Segmentation, By Country

Figure 3. Middle East & Africa Virus-like Particles Market Overview

Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Middle East & Africa Virus-like particles Market

Figure 5. Saudi Arabia to Show Significant Growth during Forecast Period

Figure 6. Middle East & Africa Virus-like Particles Market, Industry Landscape

Figure 7. Middle East & Africa PEST Analysis

Figure 8. Middle East & Africa Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9. Middle East & Africa Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10. Middle East & Africa Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Middle East & Africa Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15. Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Middle East & Africa Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20. Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Middle East & Africa Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 23. Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24. UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 26. South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 27. Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 28. Impact Of COVID-19 Pandemic in Middle East & African Countries

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa virus-like particles market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000